PTG-300 in Patients With Polycythemia Vera and Elevated Hematocrit
Clinical trial NCT04767802 · COMPLETED
Trial details
- NCT number
- NCT04767802
- Sponsor
- Protagonist Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-02
- Primary completion
- 2023-03-15
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.